ClinicalTrials.govpublic full text
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma
relapsed t-cell lymphoma, refractory t-cell lymphoma, non hodgkin lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870051
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.